India

team@businessnewsthisweek.com

9938772605

Hours: Mon – Fri 8:00am to 7:30pm

Cholamandalam Investment and Finance – FY25 Q3 Results

Chennai, January 31st, 2025: The Board of Directors of CIFCL today approved the unaudited financial results for the quarter and nine months ended 31st December 2024.

Performance Highlights:

• Aggregate disbursements in Q3 FY 25 were at ₹ 25,806 Cr as against ₹ 22,383 Cr in Q3 FY 24 registering a growth of 15%. Disbursements in YTD Dec 2024 were at ₹ 74,452 Cr as against ₹ 63,940 Cr registering a growth of 16% on Y-o-Y basis.

• Vehicle Finance (VF) disbursements were at ₹ 14,390 Cr in Q3 FY 25 as against ₹ 12,354 Cr in Q3 FY24, registering a growth of 16%. Disbursements in YTD Dec 2024, were at ₹ 39,492 Cr as against ₹ 35,385 Cr in the previous year, registering a growth of 12% Y-o-Y.

• Loan Against Property (LAP) business disbursed ₹ 4,205 Cr in Q3 FY 25, as against ₹ 3,409 Cr in Q3 FY24, registering a growth rate of 23%. Disbursements in YTD Dec 2024, were at ₹ 12,374 Cr as against ₹ 9,281 Cr in the previous year, registering a growth of 33% Y-o-Y.

• Home Loan business disbursed ₹ 1,820 Cr in Q3 FY 25, as against ₹ 1,587 Cr in Q3 FY24 registering a growth of 15%. The Disbursements in YTD Dec 2024 were at ₹ 5,421 Cr as against ₹ 4,615 Cr in the previous year, registering a growth of 17% Y-o-Y.

• Small and Medium Enterprises Loan (SME) business disbursed ₹ 1,911 Cr in Q3 FY 25, as against ₹ 1,981 Cr in Q3 FY24. The disbursements in YTD Dec 2024 were at ₹ 6,029 Cr, registering 1% growth over ₹ 5,971 Cr in YTD Dec 2023.

• Consumer and Small Enterprise Loans (CSEL) disbursed ₹ 3,149 Cr in Q3 FY 25, as against ₹ 2,773 Cr in Q3 FY24 registering a growth of 14%. The disbursements in YTD Dec 2024 were at ₹ 10,224 Cr, registering 28% growth over ₹ 7,980 Cr in YTD Dec 2023.

• Secured Business and Personal Loan (SBPL) disbursed ₹ 331 Cr in Q3 FY 25, as against ₹ 280 Cr in Q3 FY24 registering a growth of 18%. The disbursements in YTD Dec 2024 were at ₹ 911 Cr, registering 29% growth over ₹ 708 Cr in YTD Dec 2023.

• Assets under management as of 31st December 2024, stood at ₹ 1,89,141 Cr as compared to ₹ 1,41,143 Cr as of 31st December 2023, clocking a growth of 34% Y-O-Y.

• PBT Growth in Q3 was at 27% and for YTD Dec 2024 was at 28%.

• PBT-ROA for Q3 FY 25 was at 3.2% and for the YTD Dec 2024 was at 3.1%.

• ROE for Q3 FY 25 was at 19.6%. and for the YTD Dec 2024 was at 18.9%.

• The Company continues to hold a strong liquidity position with ₹ 15159 Cr as cash balance as at end of Dec’2024 (including Rs 3421 cr invested in Gsec & SDL/ Rs 1694 cr invested TBill & Rs 758 crs invested in Strips shown under investments), with a total liquidity position of ₹ 15677 Cr (including undrawn sanctioned lines). The ALM is comfortable with no negative cumulative mismatches across all time buckets.

• Consolidated Profit Before Tax (PBT) for Q3 FY 25 was at ₹ 1,465 Cr as against ₹ 1,157 Cr in Q3 FY 24 registering a growth of 27% and for YTD Dec 2024 was at ₹ 4,043 Cr as against ₹ 3,177 Cr in YTD Dec 2023 registering a growth of 27%.
Asset Quality:
Stage 3 levels representing 90+ dues increased to 2.91% as of December 24 from 2.83% as of the end of September 24. GNPA % as per RBI norms increased to 4.00% as of December 24 as against 3.78% on September 24. NNPA as per RBI norms has also increased to 2.66% as of December 24 against 2.48% on September 24. NNPA is below the threshold of 6% prescribed by RBI as the threshold for PCA.

The details of the stagewise assets and provisions are given in the Annexure.

Capital Adequacy:

The Capital Adequacy Ratio (CAR) of the company as of 31st December 2024, was at 19.76% as against the regulatory requirement of 15%. Tier-I Capital was at 14.92% (Common Equity Tier-I Capital at 14.17% as against a regulatory minimum of 9%) and Tier-II Capital was at 4.84%.

Interim Dividend
The Board of Directors of the Company approved the payment of Interim dividend of 65% being ₹ 1.30 per share on the equity shares of the Company, for the year ending March 31, 2025.

Leave a Reply

Your email address will not be published. Required fields are marked *

More Articles & Posts